These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 5805382

  • 1. Pyrrolopyrimidine nucleosides. 3. The total synthesis of toyocamycin, sangivamycin, tubercidin, and related derivatives.
    Tolman RL, Robins RK, Townsend LB.
    J Am Chem Soc; 1969 Apr 09; 91(8):2102-8. PubMed ID: 5805382
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis, cytotoxicity, and antiviral activity of some acyclic analogues of the pyrrolo[2,3-d]pyrimidine nucleoside antibiotics tubercidin, toyocamycin, and sangivamycin.
    Gupta PK, Daunert S, Nassiri MR, Wotring LL, Drach JC, Townsend LB.
    J Med Chem; 1989 Feb 09; 32(2):402-8. PubMed ID: 2913300
    [Abstract] [Full Text] [Related]

  • 3. Pyrrolopyrimidine nucleosides. V. A study on the relative chemical reactivity of the 5-cyano group of the nucleoside antibiotic toyocamycin and desaminotoyocamycin. The synthesis of analogs of sangivamycin.
    Hinshaw BC, Gerster JF, Robins RK, Townsend LB.
    J Org Chem; 1970 Jan 09; 35(1):236-41. PubMed ID: 5410625
    [No Abstract] [Full Text] [Related]

  • 4. Pyrazolopyrimidine nucleosides. Part I. Synthesis of pyrazolopyrimidine nucleosides related to the nucleoside antibiotic tubercidin.
    Revankar GR, Townsend LB.
    J Chem Soc Perkin 1; 1971 Jan 09; 13():2440-2. PubMed ID: 5166603
    [No Abstract] [Full Text] [Related]

  • 5. Pyrrolopyrimidine nucleosides. Part X. Synthesis of certain 4,5-disubstituted 7-(beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidines related to toyocamycin and sangivamycin.
    Hinshaw BC, Leonoudakis O, Schram KH, Townsend LB.
    J Chem Soc Perkin 1; 1975 Jan 09; (13):1248-53. PubMed ID: 1171884
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pyrrolo[2,3-d]pyrimidine nucleoside antibiotics. Total synthesis and structure of toyocamycin, unamycin B, vengicide, antibiotic E-212, and Sangivamycin (BA-90912).
    Tolman RL, Robins RK, Townsend LB.
    J Am Chem Soc; 1968 Jan 17; 90(2):524-6. PubMed ID: 5634627
    [No Abstract] [Full Text] [Related]

  • 8. Total synthesis of the amino sugar nucleoside antibiotic, plicacetin.
    Stevens CL, Nemec J, Ransford GH.
    J Am Chem Soc; 1972 May 03; 94(9):3280-1. PubMed ID: 5032506
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of the cellular and RNA-dependent effects of sangivamycin and toyocamycin in human colon carcinoma cells.
    Cohen MB, Glazer RI.
    Mol Pharmacol; 1985 Mar 03; 27(3):349-55. PubMed ID: 2579317
    [Abstract] [Full Text] [Related]

  • 10. Pyrazolopyrimidine nucleosides. Part II. 7-Substituted 3- -D-ribofuranosylpyrasolo(4,3-d)pyrimidines related to and derived from the nucleoside antibiotics formycin and formycin B.
    Long RA, Lewis AF, Robins RK, Townsend LB.
    J Chem Soc Perkin 1; 1971 Mar 03; 13():2443-6. PubMed ID: 5166604
    [No Abstract] [Full Text] [Related]

  • 11. Electrochemical study of the reduction of toyocamycin and sangivamycin in aqueous media.
    Bojarska E, Pawlicki K, Czochralska B.
    Acta Biochim Pol; 1987 Mar 03; 34(2):135-44. PubMed ID: 3673437
    [Abstract] [Full Text] [Related]

  • 12. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
    Renau TE, Wotring LL, Drach JC, Townsend LB.
    J Med Chem; 1996 Feb 16; 39(4):873-80. PubMed ID: 8632411
    [Abstract] [Full Text] [Related]

  • 13. Genetic and biochemical studies on mutants of CHO cells resistant to 7-deazapurine nucleosides: differences in the mechanisms of action of toyocamycin and tubercidin.
    Gupta RS, Mehta KD.
    Biochem Biophys Res Commun; 1984 Apr 16; 120(1):88-95. PubMed ID: 6712702
    [Abstract] [Full Text] [Related]

  • 14. [Synthesis of antiviral agents acyclic nucleo-sides of 4-substituted pyrrolo [2,3-d] pyrimidine].
    Jiang XJ, Zhou L, Jin J, Tao PZ.
    Yao Xue Xue Bao; 1989 Apr 16; 24(7):496-501. PubMed ID: 2618690
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: the effect of certain 4- and 4,6-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidines.
    Renau TE, Kennedy C, Ptak RG, Breitenbach JM, Drach JC, Townsend LB.
    J Med Chem; 1996 Aug 30; 39(18):3470-6. PubMed ID: 8784444
    [Abstract] [Full Text] [Related]

  • 16. A new biological role of sangivamycin; inhibition of protein kinases.
    Osada H, Sonoda T, Tsunoda K, Isono K.
    J Antibiot (Tokyo); 1989 Jan 30; 42(1):102-6. PubMed ID: 2921215
    [Abstract] [Full Text] [Related]

  • 17. Total Synthesis of Nucleoside Antibiotics Plicacetin and Streptcytosine A.
    Fu J, Laval S, Yu B.
    J Org Chem; 2018 Jul 06; 83(13):7076-7084. PubMed ID: 29436226
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and biological activity of pyrazolo[3,4,-d]pyrimidine nucleosides and nucleotides related to tubercidin, toyocamycin, and sangivamycin.
    Hecht SM, Frye RB, Werner D, Fukui T, Hawrelak SD.
    Biochemistry; 1976 Mar 09; 15(5):1005-15. PubMed ID: 766833
    [Abstract] [Full Text] [Related]

  • 19. The isolation and structure of modified bioactive nucleosides from Jaspis johnstoni.
    Zabriskie TM, Ireland CM.
    J Nat Prod; 1989 Mar 09; 52(6):1353-6. PubMed ID: 2693614
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells.
    Cohen MB, Glazer RI.
    Mol Pharmacol; 1985 Feb 09; 27(2):308-13. PubMed ID: 2578606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.